OMIBREC
Live / Registered — Registered (as of 11 Feb 2020)
What this means for you
Registered since 11 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79261303
- Registration number
- 5980340
- Mark type
- Stylized text
- Filed
- 16 May 2019
- Published for opposition
- 26 Nov 2019
- Registered
- 11 Feb 2020
- Attorney of record
- Merilee J. Arevalo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
Prosecution history
- 30 May 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Jun 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Jun 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 31 May 2020 — FINAL DISPOSITION PROCESSED
- 11 May 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2019 — PUBLISHED FOR OPPOSITION
- 06 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Oct 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Oct 2019 — ASSIGNED TO LIE
- 16 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED